We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-16.99%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$22.6B
AUM Growth
-$5.2B
Cap. Flow
+$807M
Cap. Flow %
3.57%
Top 10 Hldgs %
19.68%
Holding
2,461
New
137
Increased
1,389
Reduced
800
Closed
128

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$50M
2
CVX icon
Chevron
CVX
+$43.5M
3
WFC icon
Wells Fargo
WFC
+$33.6M
4
PSX icon
Phillips 66
PSX
+$31.6M
5
DIS icon
Walt Disney
DIS
+$31.4M

Sector Composition

Rank Sector Weight
1 Technology 22.63%
2 Healthcare 14.97%
3 Financials 14.12%
4 Consumer Discretionary 9.55%
5 Communication Services 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMAR
1976
DELISTED
Smartsheet Inc.
SMAR
$268K ﹤0.01%
+6,468
New +$294K
TRC icon
1977
Tejon Ranch
TRC
$460M
$267K ﹤0.01%
+19,023
New +$292K
HIMX
1978
Himax Technologies
HIMX
$2.19B
$266K ﹤0.01%
97,081
+39,443
+68% +$148K
OII icon
1979
Oceaneering
OII
$4.74B
$265K ﹤0.01%
90,141
+27,897
+45% +$291K
FBNC icon
1980
First Bancorp
FBNC
$2.61B
$264K ﹤0.01%
11,423
+5,159
+82% +$169K
MATW icon
1981
Matthews International
MATW
$866M
$264K ﹤0.01%
10,903
-2,182
-17% -$69.5K
CWEN.A
1982
DELISTED
Clearway Energy Class A
CWEN.A
$263K ﹤0.01%
15,314
+251
+2% +$5K
VCYT icon
1983
Veracyte
VCYT
$4.77B
$263K ﹤0.01%
10,820
-463
-4% -$11.7K
INFN
1984
DELISTED
Infinera Corporation Common Stock
INFN
$262K ﹤0.01%
49,489
+11,640
+31% +$79.9K
KPTI icon
1985
Karyopharm Therapeutics
KPTI
$159M
$261K ﹤0.01%
906
+186
+26% +$51.3K
FMBH icon
1986
First Mid Bancshares
FMBH
$1.38B
$260K ﹤0.01%
+10,956
New +$328K
PCRX icon
1987
Pacira BioSciences
PCRX
$1.06B
$259K ﹤0.01%
7,724
-2,143
-22% -$89K
DLPH
1988
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$258K ﹤0.01%
31,991
-1,087
-3% -$13.5K
AVD icon
1989
American Vanguard Corp
AVD
$70.4M
$257K ﹤0.01%
+17,797
New +$296K
CTS icon
1990
CTS Corp
CTS
$1.79B
$256K ﹤0.01%
10,275
+2,009
+24% +$54.7K
GME icon
1991
GameStop
GME
$9.82B
$256K ﹤0.01%
292,752
-816,272
-74% -$874K
CVCO icon
1992
Cavco Industries
CVCO
$4.33B
$255K ﹤0.01%
1,756
+262
+18% +$51.5K
DENN
1993
DELISTED
Denny's
DENN
$255K ﹤0.01%
33,237
-14,915
-31% -$253K
VNDA icon
1994
Vanda Pharmaceuticals
VNDA
$312M
$255K ﹤0.01%
24,629
+7,405
+43% +$91.8K
ZUMZ icon
1995
Zumiez
ZUMZ
$334M
$255K ﹤0.01%
14,715
+3,792
+35% +$107K
IMMU
1996
DELISTED
Immunomedics Inc
IMMU
$255K ﹤0.01%
18,908
-5,324
-22% -$89.6K
ADT icon
1997
ADT
ADT
$5.51B
$254K ﹤0.01%
58,900
+46,854
+389% +$283K
UBA
1998
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$254K ﹤0.01%
18,041
-13,512
-43% -$279K
INO icon
1999
Inovio Pharmaceuticals
INO
$54M
$252K ﹤0.01%
+2,819
New +$174K
PLOW icon
2000
Douglas Dynamics
PLOW
$991M
$252K ﹤0.01%
7,090
-1,365
-16% -$64K

Similar funds

Aperio Group's Q1 2020 Portfolio in Review

As of Q1 2020, Aperio Group held 2,461 positions worth $22.6B, down 19% from $27.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aperio Group deployed $807M of net new capital in Q1 2020, opening 137 new positions and adding to 1,389 existing holdings. Its largest new stake was Ingersoll Rand: 170,073 shares worth $4.22M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was PepsiCo, an estimated $50M trimmed.

  • Aperio Group's largest Q1 2020 buy was Ingersoll Rand: 170,073 shares worth $4.22M.
  • Aperio Group added most to Amazon in Q1 2020, an estimated $72.4M increase.
  • Aperio Group's biggest Q1 2020 reduction was PepsiCo, cutting an estimated $50M.
  • Aperio Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $9.6M.
  • Aperio Group's ten largest holdings make up 20% of its $22.6B portfolio in Q1 2020.
  • Aperio Group opened 137 new positions and closed 128 in Q1 2020.
  • Aperio Group's portfolio value fell 19% quarter-over-quarter to $22.6B.

Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.